nivolumab
bms
['nivo']
research on neoantigen immunogenicity during immunotherapy w/nivo has come a long way, as reported by tyler j alban at #aacr23. here is a look at analyses taking place for neoantigen-specific cd4 t cells during response to anti-pd-l1 in metastatic mcc. 
The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Interim Editor-in-Chief: James L. Gulley (@gulley1)